CD8+ T Suppressor Cells Are Back to the Game: Are They Players in Autoimmunity?
Overview
Authors
Affiliations
The CD8+ T suppressor lymphocytes identified in humans belong to three different subpopulations. All of them inhibit the proliferation of antigen-specific T cells. The type 1 and type 2 of CD8+ T suppressor cells are characterized by the CD8+CD28- phenotype, while no detailed data are available at the moment on the phenotype of the type 3 of CD8+ T suppressor cells. The type 1 of CD8+ suppressor T lymphocytes acts by inducing alteration of expression of co-stimulatory molecules on dendritic cells. A cell-to-cell contact is required to mediate this effect. The type 2 of CD8+ T suppressor cells induces inhibition via cytokine secretion (IFNgamma, IL6) and do not need to interact directly with antigen presenting cells. The type 3 of CD8+ T suppressor cells mediates its function through the secretion of IL10. The complexity and multiplicity of CD8+ T suppressor cell subsets suggests that these cells may have an important role in the regulation of the immune homeostasis, acting together with the CD4+ T regulatory cell subpopulations. The specificity of the functions of each of these suppressor/regulatory subsets in the immune network requires to be clarified to better understand the immune system, its functions and the possibilities to modulate its activities in the course of immune-mediated diseases.
Yu X, Lin Y, Chen H, Wu M, Huang L, Song Y BMC Pulm Med. 2022; 22(1):291.
PMID: 35907816 PMC: 9338636. DOI: 10.1186/s12890-022-02088-7.
Regulatory T-Cells and Multiple Myeloma: Implications in Tumor Immune Biology and Treatment.
Hadjiaggelidou C, Katodritou E J Clin Med. 2021; 10(19).
PMID: 34640606 PMC: 8509132. DOI: 10.3390/jcm10194588.
Wang T, Fei Y, Yao M, Tao J, Deng J, Huang B Pain Res Manag. 2020; 2020:8730918.
PMID: 32351643 PMC: 7178466. DOI: 10.1155/2020/8730918.
Pellegrino M, Crino A, Rosado M, Fierabracci A PLoS One. 2019; 14(1):e0210839.
PMID: 30650147 PMC: 6334945. DOI: 10.1371/journal.pone.0210839.
Phenotypic Alterations Involved in CD8+ Treg Impairment in Systemic Sclerosis.
Negrini S, Fenoglio D, Parodi A, Kalli F, Battaglia F, Nasi G Front Immunol. 2017; 8:18.
PMID: 28154567 PMC: 5243838. DOI: 10.3389/fimmu.2017.00018.